Erratum: Prokaryotic expression, purification and functional characterization of recombinant human RIP2 (Molecular Biology Reports DOI:10.1007/s11033-012-1995-z);Prokaryotic expression, purification and functional characterization of recombinant human RIP2

Molecular Biology Reports

Volumn 40, Issue 1, 2013, Pages 59-65

  Cai, Xin ^a   Wang, Min ^a   Kong, Haibo ^b   Liu, Jing ^c   Liu, Ye ^a   Xia, Wengrong ^a   Zou, Minji ^a   Wang, Jiaxi ^a   Su, Hang ^c   Xu, Donggang ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Bcl xL; Prokaryotic expression; Purification; Receptor interacting protein 2 (RIP2)

Indexed keywords

B CELL ACTIVATING FACTOR; BETA ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL XL; PROTEIN P52; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN 2; RECOMBINANT PROTEIN; RECOMBINANT RECEPTOR INTERACTING PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL LYSATE; CELL PROLIFERATION; CELL STRAIN MCF 7; ESCHERICHIA COLI; EXPRESSION VECTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA CELL; MOLECULAR CLONING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROKARYOTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; RECOMBINANT PLASMID; SIGNAL TRANSDUCTION; SUPERNATANT;

PROKARYOTA;

EID: 84871330685     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2335-z     Document Type: Erratum

References (33)

1. McCarthy JV, Ni J, Dixit VM (1998) RIP2 is a novel NF-kappaB activating and cell death-inducing kinase. J Biol Chem 273:16968-16975
2. Inohara N, DelPeso L, Koseki T, Chen S, Nunez G (1998) RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J Biol Chem 273:12296-12300
3. Thome M, Hofmann K, Burns K, Martinon F, Bodmer JL, Mattmann C, Tschopp J (1998) Identification of CARDIAK, a RIPlike kinase that associates with caspase-1. Curr Biol 8:885-888
4. Stanger BZ, Leder P, Lee TH, Kim E, Seed B (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513-523
5. Meylan E, Martinon F, Thome M, Gschwendt M, Tschopp J (2002) RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis. EMBO Rep 3:1201-1208
6. Yu PW, Huang BC, Shen M, Quast J, Chan E, Xu X, Nolan GP, Payan DG, Luo Y (1999) Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr Biol 9:539-542
7. Sun X, Lee J, Navas T, Baldwin DT, Stewart TA, Dixit VM (1999) RIP3, a novel apoptosis-inducing kinase. J Biol Chem 274:16871-16875
8. Zha J, Zhou Q, Xu LG, Chen D, Li L, Zhai Z, Shu HB (2004) RIP5 is a RIP-homologous inducer of cell death. Biochem Biophys Res Commun 319:298-303
9. Meylan E, Tschopp J (2005) The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30:151-159
10. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, Janeway CA, Medzhitov R, Flavell RA (2002) RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416:194-199
11. Ehlers S, Mueck T, Adams S, Landuzzi L, Lollini PL, Munz B (2008) RIP2 regulates growth and differentiation of normal myoblasts and of rhabdomyosarcoma cells. Eur J Cell Biol 87:163-172
12. Adams S, Valchanova RS, Munz B (2010) RIP2: a novel player in the regulation of keratinocyte proliferation and cutaneous wound repair? Exp Cell Res 316:728-736
13. Hasegawa M, Fujimoto Y, Lucas P, Nakano H, Fukase K, Nu′nË œez G, Inohara N (2008) A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-κB activation. EMBO J 27:373-383
14. Wada K, Maeda K, Tajima K, Kato T, Kobata T, Yamakawa M (2009) Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas. Histopathology 54(2):221-232
15. Pham LV, Fu L, Tamayo AT, Bueso-Ramos C, Drakos E, Vega F, Medeiros LJ, Ford RJ (2011) Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways. Blood 117(1):200-210
16. Studier FW, MoVatt BA (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189:113-130
17. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr (1997) Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629-3639
18. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE (1997) Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Investig 100:2952-2960
19. Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE (2007) Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 9(4):470-478
20. Gavert N, Ben-Ze'ev A (2008) Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 14:199-209
21. Kim DS, Park KS, Kim SY (2009) Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors. Front Biosci 14:2514-2521
22. Jinsong Y, Ming S, Aiping Z, Chengyu L, Wei D, Zhaoxia W (2011) Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells. World J Surg Oncol 9:117
23. Watanabe J, Kushihata F, Honda K, Mominoki K, Matsuda S, Kobayashi N (2002) Bcl-xL overexpression in human hepatocellular carcinoma. Int J Oncol 21:515-519
24. Castilla C, Congregado B, Chinchón D, Torrubia FJ, Japón MA, Sáez C (2006) Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak. Endocrinology 147:4960-4967
25. Wang ZX, Yang JS, Pan X, Wang JR, Li J, Yin YM, De W (2010) Functional and biological analysis of Bcl-xL expression in human osteosarcoma. Bone 47:445-454
26. Hildebrand JM, Luo Z, Manske MK, Price-Troska T, Ziesmer SC, Lin W, Hostager BS, Slager SL, Witzig TE, Ansell SM, Cerhan JR, Bishop GA, Novak AJ (2010) A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling. J Exp Med 207(12):2569-2579
27. Mackay F, Figgett WA, Saulep D, Lepage M, Hibbs ML (2010) B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor. Immunol Rev 237(1):205-225
28. Onda K, Iijima K, Katagiri YU, Okita H, Saito M, Shimizu T, Kiyokawa N (2010) Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma. Int J Hematol 91(5):808-819
29. Fu L, Lin-Lee YC, Pham LV, Tamayo A, Yoshimura L, Ford RJ (2006) Constitutive NF-κB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 107:4540-4548
30. Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, Browning JL, Mackay F (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453-1466
31. Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-kiang S (2000) Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 192:953-964
32. Rolink AG, Tschopp J, Schneider P, Melchers F (2002) BAFF is a survival and maturation factor for mouse B cells. Eur J Immunol 14:266-275
33. Huang X, Di Liberto M, Cunningham AF, Kang L, Cheng S, Ely S, Liou HC, Maclennan IC, Chen-Kiang S (2004) Homeostatic cell-cycle control by BLyS: induction of cell-cycle entry but not G1/S transition in opposition to p18 INK4c and p27 Kip1. Proc Natl Acad Sci USA 101: 17789-17794